Zucca E, Ceriani L, Ciccone G, Di Rocco A, Pirosa MC, Kriachok I, Botto B, Balzarotti M, Tucci A, Usai SV, Zilioli VR, Pennese E, Arcaini L, Dabrowska-Iwanicka AP, Ferreri AJM, Merli F, Zhao WL, Rigacci L, Cellini C, Hodgson D, Ionescu C, Minoia C, Lucchini E, Spina M, Fosså Aet al.(2025) Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trial Blood(in press) DOI 10.1182/blood.2025028823, PubMed 40939190
Trewin-Nybråten CB, Lambert PC, Marienhagen K, Andreassen L, Johannesen TB, Niehusmann P, Oltedal L, Schipmann S, Skjulsvik AJ, Solheim O, Solheim TS, Sundstrøm T, Vik-Mo EO, Brandal P, Ingebrigtsen T, Skaga E, advisory board for the Norwegian Brain and Spinal Cord Tumour Registry(2025) Unveiling regional differences in glioblastoma patient survival with real-world data from the Norwegian brain tumor quality registry J Neurooncol(in press) DOI 10.1007/s11060-025-05218-3, PubMed 40932639
Abrantes R, Forcados C, Warren DJ, Santos-Ferreira L, Fleten KG, Senra E, Costa AF, Krpina K, Henrique R, Liberg AM, Rawat P, Gelebart P, McCormack E, Bjørge L, Davidson B, Greiff V, Costea DE, Pinto F, Flatmark K, Gomes C, Inderberg EM, Reis CA, Wälchli S(2025) Pan-carcinoma sialyl-Tn-targeting expands CAR therapy to solid tumors Cell Rep Med, 102350(in press) DOI 10.1016/j.xcrm.2025.102350, PubMed 40925376
